<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1039/c6ra23620k</dc:identifier><dc:language>eng</dc:language><dc:creator>Español, L.</dc:creator><dc:creator>Larrea, A.</dc:creator><dc:creator>Andreu, V.</dc:creator><dc:creator>Mendoza, G.</dc:creator><dc:creator>Arruebo, M.</dc:creator><dc:creator>Sebastian, V.</dc:creator><dc:creator>Aurora-Prado, M.S.</dc:creator><dc:creator>Kedor-Hackmann, E.R.M.</dc:creator><dc:creator>Santoro, M.I.R.M.</dc:creator><dc:creator>Santamaria, J.</dc:creator><dc:title>Dual encapsulation of hydrophobic and hydrophilic drugs in PLGA nanoparticles by a single-step method: Drug delivery and cytotoxicity assays</dc:title><dc:identifier>ART-2016-98829</dc:identifier><dc:description>Dual drug encapsulation in biodegradable nanoparticles is always challenging and often requires strenuous optimization of the synthesis-encapsulation processes. This becomes even more difficult when the simultaneous encapsulation of molecules of different polarity is sought. Here we present a modified emulsification-evaporation process to produce polymeric nanoparticles (NPs) made of the biocompatible and biodegradable polymer poly(lactic-co-glycolic acid) (PLGA) and co-encapsulating simultaneously two different drugs, the hydrophobic dexamethasone (DX) and the hydrophilic diclofenac sodium (DS). Three independent processing parameters were systematically modified to promote the incorporation of the different-polarity drugs into PLGA and to control the particle size under 150 nm. The careful selection of the appropriate solvents (ethyl acetate and methanol) was a key requirement for the successful encapsulation of DX and DS. DS and DX release kinetics as well as cytotoxicity assays underlined the therapeutic potential of the dual encapsulation strategy. © 2016 The Royal Society of Chemistry.</dc:description><dc:date>2016</dc:date><dc:source>http://zaguan.unizar.es/record/61502</dc:source><dc:doi>10.1039/c6ra23620k</dc:doi><dc:identifier>http://zaguan.unizar.es/record/61502</dc:identifier><dc:identifier>oai:zaguan.unizar.es:61502</dc:identifier><dc:relation>info:eu-repo/grantAgreement/EC/FP7/321642/EU/Development of a microfluidic platform to produce nanomaterials and assessment on new nanotechnology applications/PLATFORM2NANO</dc:relation><dc:relation>info:eu-repo/grantAgreement/EC/FP7/614715/EU/A Photo-triggered On-demand Drug Delivery System for Chronic Pain/NANOHEDONISM</dc:relation><dc:identifier.citation>RSC Advances 6, 112 (2016), 111060-111069</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>